002950.SZ
Allmed Medical Products Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 9.14
−1.83%Year over year
Reported trailing growth
- Revenue
- +14.1%
- EBITDA
- —
- EBIT
- -25.4%
- EPS
- -25.1%
- Free cash flow
- -49.3%
- Operating cash flow
- -19.5%
Forward estimates
Based on analyst estimates
- Revenue
- -75.7%
- EBITDA
- -70.3%
- EPS
- -70.6%
Three-year CAGR
- Revenue
- -4.5%
- EBITDA
- -8.0%
- EBIT
- -15.2%
- Net income
- -15.1%
- EPS
- -14.5%
- Free cash flow
- -15.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026